AG

Andrew Gasparrini

Associate Director at Empress Therapeutics

Andrew Gasparrini started their work experience as a Research Assistant at the University of Notre Dame in January 2012. Andrew then served as a Resident Assistant from August 2013 to May 2014. Following that, Andrew joined Washington University School of Medicine as a PhD Candidate in June 2014, where they worked until October 2018. In November 2018, they began working at EmpressTx as a Scientist. Andrew then progressed to the role of Senior Scientist in June 2020 and is currently serving as the Principal Scientist, starting from March 2022.

Andrew Gasparrini completed their Bachelor of Science degree in Biochemistry from the University of Notre Dame in the years 2010-2014. Andrew then pursued a Doctor of Philosophy (Ph.D.) in Molecular Genetics and Genomics at the Washington University School of Medicine in St. Louis from 2014-2018. Prior to their undergraduate studies, Andrew attended Ridgefield High School from 2006-2010, although no degree or field of study is specified.

Links

Previous companies

University of Notre Dame logo

Org chart